Comparison Between Conventional Angiocatheter Versus New Anchoring Device (KARAHOC) Used for Paracentesis

Sponsor
Sang Gyune Kim (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05578573
Collaborator
(none)
80
1
2
11.4
7

Study Details

Study Description

Brief Summary

Comparison of success rate and complication between conventional angiocatheter versus new anchoring device (KARAHOC) used for paracentesis in cirrhotic patients with ascites.

Condition or Disease Intervention/Treatment Phase
  • Device: KARAHOC device
  • Device: Angiocatheter
N/A

Detailed Description

This study is a multi-center, prospective, interventional study, in which subjects who meet the selection criteria are registered at each institution during the study period from the date of research approval. Regardless of the order, paracentesis using KARAHOC and conventional angiocatheter will be performed once in all patients. The criteria for successful paracentesis is set as 3L or more of ascites drainage. During paracentesis, albumin will be infused in all patients. Heart rate and blood pressure will be measured before the procedure and right after the completion of drainage, and 30 minutes later. The incidence of complications will be compared between two methods. In addition, patient and operator satisfaction will be investigated using a visual analogue scale.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
multi-center, prospective, interventional studymulti-center, prospective, interventional study
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparison of Success Rate and Complication Between Conventional Angiocatheter Versus New Anchoring Device (KARAHOC) Used for Paracentesis in Cirrhotic Patients With Ascites
Actual Study Start Date :
Jan 17, 2022
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: KARAHOC group

A group of patients in which paracentesis will be performed using a KARAHOC device.

Device: KARAHOC device
After leaving a mark on the part where the puncture is to be performed using a pen, sterilization dressing are performed, local anesthesia is performed aseptic then ascites paracentesis by KARAHOC device.

Active Comparator: conventional group

A group of patients in which paracentesis will be performed using an angiocatheter.

Device: Angiocatheter
After leaving a mark on the part where the puncture is to be performed using a pen, sterilization dressing are performed, local anesthesia is performed aseptic then ascites paracentesis by angiocatheter

Outcome Measures

Primary Outcome Measures

  1. Comparison of success rate between conventional angiocatheter versus KARAHOC device used for paracentesis [through study completion, an average of 1 year]

    The criterion for successful paracentesis is defined as drainage of 3L or more at an initial attempt.

Secondary Outcome Measures

  1. comparison of complication rate [through study completion, an average of 1 year]

    the frequency of bleeding, hypotension, acute kidney injury, infection

  2. operator satisfaction for each procedure [through study completion, an average of 1 year]

    measure the amount of satisfaction using visual analogue scales distributed from 1 to 10, higher score means better outcome

  3. patient satisfaction for each procedure [through study completion, an average of 1 year]

    measure the amount of satisfaction using visual analogue scales distributed from 1 to 10, higher score means better outcome

  4. Number of Participants with repeated paracentesis [through study completion, an average of 1 year]

    Whether to do paracentesis again due to initial failure or catheter dislocation

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult over the age of 19

  • Patients with pathological or clinical diagnosis of liver cirrhosis

  • Patients with Grade 2 or higher grade of ascites as a complication due to portal hypertension

  • Patients requiring periodic paracentesis

  • Patients consent to this study

Exclusion Criteria:(If at least one of the following conditions apply)

  • Patients with ascites due to peritoneal metastasis due to malignant tumor

  • Patients with high bleeding risk (PT INR>3, PLT<30,000/mm3) difficult to perform ascites puncture

  • Patients with hepatic encephalopathy or hepatorenal syndrome(HRS)

  • Patients with severe cardiovascular disease, lung disease, or DIC

  • Patients refusing paracentesis

  • Patients who can control ascites using diuretics

  • Pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Soon Chun Hyang University Bucheon Hospital Bucheon Gyeonggi Do Korea, Republic of 14584

Sponsors and Collaborators

  • Sang Gyune Kim

Investigators

  • Principal Investigator: Sang gyune Kim, PhD, Soonchunhyang University Hospital

Study Documents (Full-Text)

More Information

Publications

Responsible Party:
Sang Gyune Kim, Professor, Soonchunhyang University Hospital
ClinicalTrials.gov Identifier:
NCT05578573
Other Study ID Numbers:
  • KARAHOC STUDY
First Posted:
Oct 13, 2022
Last Update Posted:
Oct 13, 2022
Last Verified:
Oct 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Sang Gyune Kim, Professor, Soonchunhyang University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 13, 2022